Alembic Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 9, 2025, 11:25 am

Market Cap	2,740 Cr.
Current Price	107
High / Low	169/85.5
Stock P/E	8.85
Book Value	91.1
Dividend Yield	2.25 %
ROCE	6.90 %
ROE	13.7 %
Face Value	2.00
PEG Ratio	-4.55

Quick Insight

Alembic Ltd, operating in the realty sector, presents a compelling investment case with its share price at ₹112 and a market capitalization of ₹2,863 crore. The company boasts a price-to-earnings (P/E) ratio of 9.24, indicating potential undervaluation compared to industry peers. With a robust return on equity (ROE) of 13.7% and an operating profit margin (OPM) of 45%, Alembic demonstrates strong profitability. Additionally, its low borrowings of ₹14 crore against reserves of ₹2,287 crore highlight financial stability. However, a concerning cash conversion cycle (CCC) of 2,502 days may impede operational efficiency. Given these factors, investors should weigh the attractive valuations against operational challenges, but the overall metrics suggest a cautiously optimistic outlook.

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Alembic Ltd

Competitors of Alembic Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Hampton Sky Realty Ltd	599 Cr.	21.8	35.8/20.3	109	5.32	0.00 %	6.09 %	3.86 %	1.00
Grovy India Ltd	57.4 Cr.	43.0	98.2/37.4	18.3	15.3	0.06 %	7.60 %	9.12 %	10.0
Gothi Plascon (India) Ltd	45.4 Cr.	44.5	53.6/32.2	29.9	11.0	4.49 %	18.8 %	14.2 %	10.0
Generic Engineering Construction & Projects Ltd	242 Cr.	41.8	54.6/22.0	19.9	49.9	0.00 %	9.36 %	4.43 %	5.00
Garnet Construction Ltd	50.8 Cr.	36.6	57.2/21.6	6.86	74.0	0.00 %	9.98 %	7.47 %	10.0
Industry Average	18,202.64 Cr	431.10		72.59	142.74	0.57%	12.14%	10.41%	6.13

All Competitor Stocks of Alembic Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	18	22	37	31	37	37	32	39	49	51	53	58	60
Expenses	15	17	26	20	24	26	22	28	25	30	33	32	33
Operating Profit	3	5	11	10	13	11	10	12	24	20	20	26	27
OPM %	16%	25%	30%	34%	36%	30%	31%	30%	49%	40%	37%	46%	45%
Other Income	4	1	59	2	-9	3	48	2	2	2	66	4	3
Interest	0	0	0	0	0	0	0	0	0	0	1	1	1
Depreciation	1	2	2	2	2	2	2	3	1	2	3	3	3
Profit before tax	6	4	68	11	3	12	56	11	24	19	82	27	27
Tax %	20%	11%	10%	2%	-55%	14%	8%	9%	12%	10%	6%	5%	12%
Net Profit	1	-19	115	46	48	44	91	61	72	56	121	65	68
EPS in Rs	0.04	-0.72	4.49	1.78	1.88	1.73	3.53	2.39	2.81	2.17	4.71	2.55	2.67

Last Updated: May 31, 2025, 9:53 am

Below is a detailed analysis of the quarterly data for Alembic Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Dec 2024) to 60.00 Cr., marking an increase of 2.00 Cr..
For Expenses, as of Mar 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.00 Cr. (Dec 2024) to 33.00 Cr., marking an increase of 1.00 Cr..
For Operating Profit, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Dec 2024) to 27.00 Cr., marking an increase of 1.00 Cr..
For OPM %, as of Mar 2025, the value is 45.00%. The value appears to be declining and may need further review. It has decreased from 46.00% (Dec 2024) to 45.00%, marking a decrease of 1.00%.
For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Dec 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
For Profit before tax, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 27.00 Cr..
For Tax %, as of Mar 2025, the value is 12.00%. The value appears to be increasing, which may not be favorable. It has increased from 5.00% (Dec 2024) to 12.00%, marking an increase of 7.00%.
For Net Profit, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Dec 2024) to 68.00 Cr., marking an increase of 3.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 2.67. The value appears strong and on an upward trend. It has increased from 2.55 (Dec 2024) to 2.67, marking an increase of 0.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:20 am

Metric	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	1,121	144	134	147	125	124	74	74	78	127	157	222
Expenses	1,018	134	128	140	114	106	71	62	64	87	101	128
Operating Profit	103	10	6	7	11	18	3	11	14	40	57	94
OPM %	9%	7%	5%	5%	9%	15%	4%	15%	18%	32%	36%	42%
Other Income	16	21	25	25	37	29	93	10	89	54	55	75
Interest	32	1	0	0	0	0	0	0	0	0	1	2
Depreciation	43	6	6	5	4	3	3	4	5	7	8	11
Profit before tax	44	23	25	27	44	45	93	17	98	87	103	156
Tax %	10%	-3%	2%	-3%	5%	8%	0%	19%	12%	7%	10%	7%
Net Profit	40	107	235	145	163	213	329	343	222	191	269	311
EPS in Rs	1.48	3.99	8.78	5.45	6.10	8.30	12.82	13.35	8.65	7.42	10.46	12.10
Dividend Payout %	17%	4%	2%	4%	3%	2%	5%	2%	21%	30%	23%	20%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	119.63%	-38.30%	12.41%	30.67%	54.46%	4.26%	-35.28%	-13.96%	40.84%	15.61%
Change in YoY Net Profit Growth (%)	0.00%	-157.92%	50.71%	18.26%	23.79%	-50.20%	-39.53%	21.31%	54.80%	-25.22%

Alembic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	4%
5 Years:	25%
3 Years:	42%
TTM:	41%

Compounded Profit Growth
10 Years:	11%
5 Years:	-1%
3 Years:	12%
TTM:	16%

Stock Price CAGR
10 Years:	12%
5 Years:	4%
3 Years:	15%
1 Year:	-26%

Return on Equity
10 Years:	15%
5 Years:	12%
3 Years:	12%
Last Year:	14%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:31 pm

Month	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	27	53	53	53	53	51	51	51	51	51	51	51
Reserves	311	474	750	858	1,032	1,157	1,367	2,246	2,445	2,027	2,134	2,287
Borrowings	408	0	9	0	0	0	0	0	0	0	9	14
Other Liabilities	251	91	64	81	73	57	53	112	135	127	134	150
Total Liabilities	997	619	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503
Fixed Assets	393	169	146	171	179	209	225	265	297	321	369	409
CWIP	4	2	0	0	0	0	3	6	0	0	1	0
Investments	8	299	605	732	913	1,001	1,133	2,047	2,208	1,754	1,786	1,900
Other Assets	591	149	124	89	67	55	110	91	127	130	173	194
Total Assets	997	619	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503

Below is a detailed analysis of the balance sheet data for Alembic Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 51.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 51.00 Cr..
For Reserves, as of Mar 2025, the value is 2,287.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,134.00 Cr. (Mar 2024) to 2,287.00 Cr., marking an increase of 153.00 Cr..
For Borrowings, as of Mar 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 5.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 134.00 Cr. (Mar 2024) to 150.00 Cr., marking an increase of 16.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 2,503.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,329.00 Cr. (Mar 2024) to 2,503.00 Cr., marking an increase of 174.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 409.00 Cr.. The value appears strong and on an upward trend. It has increased from 369.00 Cr. (Mar 2024) to 409.00 Cr., marking an increase of 40.00 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
For Investments, as of Mar 2025, the value is 1,900.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,786.00 Cr. (Mar 2024) to 1,900.00 Cr., marking an increase of 114.00 Cr..
For Other Assets, as of Mar 2025, the value is 194.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 194.00 Cr., marking an increase of 21.00 Cr..
For Total Assets, as of Mar 2025, the value is 2,503.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,329.00 Cr. (Mar 2024) to 2,503.00 Cr., marking an increase of 174.00 Cr..

Notably, the Reserves (2,287.00 Cr.) exceed the Borrowings (14.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	149	22	10	52	24	22	7	-2	-18	39	23	86
Cash from Investing Activity +	-24	5	-5	-47	-22	68	57	-35	19	7	26	-27
Cash from Financing Activity +	-118	-25	-5	-5	-3	-89	-6	-15	-6	-46	-48	-58
Net Cash Flow	7	2	-0	-0	-1	1	57	-52	-5	-0	0	1

Free Cash Flow

Month	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-305.00	10.00	-3.00	7.00	11.00	18.00	3.00	11.00	14.00	40.00	48.00	80.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

No data available for the Financial Efficiency data table.

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%
FIIs	1.23%	1.19%	1.12%	1.08%	0.83%	0.82%	0.70%	0.72%	0.85%	0.89%	1.07%	1.42%
DIIs	4.89%	5.17%	4.69%	4.29%	4.12%	3.94%	3.94%	3.93%	3.40%	0.04%	0.04%	0.04%
Public	23.00%	22.76%	23.31%	23.75%	24.16%	24.34%	24.48%	24.46%	24.87%	28.17%	28.02%	27.66%
No. of Shareholders	80,561	78,381	80,135	83,006	83,612	83,630	82,339	81,732	82,947	94,012	99,130	98,478

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
SBI Small Cap Fund	10,000,000	0.39	81.35	10,000,000	2025-04-22 14:12:25	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	10.46	7.42	8.65	13.35	12.82
Diluted EPS (Rs.)	10.46	7.42	8.65	13.35	12.82
Cash EPS (Rs.)	3.92	3.40	3.55	0.69	3.75
Book Value[Excl.RevalReserv]/Share (Rs.)	85.11	80.93	97.23	89.45	55.22
Book Value[Incl.RevalReserv]/Share (Rs.)	85.11	80.93	97.23	89.45	55.22
Revenue From Operations / Share (Rs.)	6.13	4.96	3.05	2.86	2.88
PBDIT / Share (Rs.)	4.35	4.07	4.02	0.83	3.77
PBIT / Share (Rs.)	4.04	3.81	3.83	0.67	3.64
PBT / Share (Rs.)	4.00	3.38	3.81	0.66	3.63
Net Profit / Share (Rs.)	3.62	3.14	3.36	0.53	3.62
NP After MI And SOA / Share (Rs.)	10.46	7.42	8.65	13.35	12.82
PBDIT Margin (%)	70.88	82.20	131.82	29.03	130.77
PBIT Margin (%)	65.90	76.91	125.60	23.67	126.41
PBT Margin (%)	65.20	68.21	125.10	23.18	126.02
Net Profit Margin (%)	58.96	63.35	110.19	18.82	125.84
NP After MI And SOA Margin (%)	170.56	149.83	283.89	466.35	445.19
Return on Networth / Equity (%)	12.29	9.17	8.89	14.92	23.20
Return on Capital Employeed (%)	4.63	4.61	3.83	0.74	6.55
Return On Assets (%)	11.53	8.64	8.43	14.23	22.37
Asset Turnover Ratio (%)	0.06	0.05	0.04	0.06	0.08
Current Ratio (X)	1.52	2.05	2.12	1.72	3.56
Quick Ratio (X)	0.49	0.99	0.83	0.80	2.78
Inventory Turnover Ratio (X)	0.09	0.07	0.12	0.26	0.69
Dividend Payout Ratio (NP) (%)	21.03	24.24	2.31	4.49	1.88
Dividend Payout Ratio (CP) (%)	20.43	23.41	2.26	4.44	1.86
Earning Retention Ratio (%)	78.97	75.76	97.69	95.51	98.12
Cash Earning Retention Ratio (%)	79.57	76.59	97.74	95.56	98.14
Interest Coverage Ratio (X)	100.70	224.79	265.00	58.96	335.70
Interest Coverage Ratio (Post Tax) (X)	84.77	197.06	222.52	39.24	324.04
Enterprise Value (Cr.)	2154.92	1520.56	1855.97	2634.71	857.86
EV / Net Operating Revenue (X)	13.68	11.95	23.73	35.84	11.60
EV / EBITDA (X)	19.30	14.54	18.00	123.44	8.87
MarketCap / Net Operating Revenue (X)	13.64	11.97	23.75	35.92	12.40
Retention Ratios (%)	78.96	75.75	97.68	95.50	98.11
Price / BV (X)	0.98	0.73	0.74	1.15	0.64
Price / Net Operating Revenue (X)	13.64	11.97	23.75	35.93	12.40
EarningsYield	0.12	0.12	0.11	0.12	0.35

After reviewing the key financial ratios for Alembic Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 10.46. This value is within the healthy range. It has increased from 7.42 (Mar 23) to 10.46, marking an increase of 3.04.
For Diluted EPS (Rs.), as of Mar 24, the value is 10.46. This value is within the healthy range. It has increased from 7.42 (Mar 23) to 10.46, marking an increase of 3.04.
For Cash EPS (Rs.), as of Mar 24, the value is 3.92. This value is within the healthy range. It has increased from 3.40 (Mar 23) to 3.92, marking an increase of 0.52.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 85.11. It has increased from 80.93 (Mar 23) to 85.11, marking an increase of 4.18.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 85.11. It has increased from 80.93 (Mar 23) to 85.11, marking an increase of 4.18.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 6.13. It has increased from 4.96 (Mar 23) to 6.13, marking an increase of 1.17.
For PBDIT / Share (Rs.), as of Mar 24, the value is 4.35. This value is within the healthy range. It has increased from 4.07 (Mar 23) to 4.35, marking an increase of 0.28.
For PBIT / Share (Rs.), as of Mar 24, the value is 4.04. This value is within the healthy range. It has increased from 3.81 (Mar 23) to 4.04, marking an increase of 0.23.
For PBT / Share (Rs.), as of Mar 24, the value is 4.00. This value is within the healthy range. It has increased from 3.38 (Mar 23) to 4.00, marking an increase of 0.62.
For Net Profit / Share (Rs.), as of Mar 24, the value is 3.62. This value is within the healthy range. It has increased from 3.14 (Mar 23) to 3.62, marking an increase of 0.48.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 10.46. This value is within the healthy range. It has increased from 7.42 (Mar 23) to 10.46, marking an increase of 3.04.
For PBDIT Margin (%), as of Mar 24, the value is 70.88. This value is within the healthy range. It has decreased from 82.20 (Mar 23) to 70.88, marking a decrease of 11.32.
For PBIT Margin (%), as of Mar 24, the value is 65.90. This value exceeds the healthy maximum of 20. It has decreased from 76.91 (Mar 23) to 65.90, marking a decrease of 11.01.
For PBT Margin (%), as of Mar 24, the value is 65.20. This value is within the healthy range. It has decreased from 68.21 (Mar 23) to 65.20, marking a decrease of 3.01.
For Net Profit Margin (%), as of Mar 24, the value is 58.96. This value exceeds the healthy maximum of 10. It has decreased from 63.35 (Mar 23) to 58.96, marking a decrease of 4.39.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 170.56. This value exceeds the healthy maximum of 20. It has increased from 149.83 (Mar 23) to 170.56, marking an increase of 20.73.
For Return on Networth / Equity (%), as of Mar 24, the value is 12.29. This value is below the healthy minimum of 15. It has increased from 9.17 (Mar 23) to 12.29, marking an increase of 3.12.
For Return on Capital Employeed (%), as of Mar 24, the value is 4.63. This value is below the healthy minimum of 10. It has increased from 4.61 (Mar 23) to 4.63, marking an increase of 0.02.
For Return On Assets (%), as of Mar 24, the value is 11.53. This value is within the healthy range. It has increased from 8.64 (Mar 23) to 11.53, marking an increase of 2.89.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.06. It has increased from 0.05 (Mar 23) to 0.06, marking an increase of 0.01.
For Current Ratio (X), as of Mar 24, the value is 1.52. This value is within the healthy range. It has decreased from 2.05 (Mar 23) to 1.52, marking a decrease of 0.53.
For Quick Ratio (X), as of Mar 24, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.99 (Mar 23) to 0.49, marking a decrease of 0.50.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 4. It has increased from 0.07 (Mar 23) to 0.09, marking an increase of 0.02.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 21.03. This value is within the healthy range. It has decreased from 24.24 (Mar 23) to 21.03, marking a decrease of 3.21.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 20.43. This value is within the healthy range. It has decreased from 23.41 (Mar 23) to 20.43, marking a decrease of 2.98.
For Earning Retention Ratio (%), as of Mar 24, the value is 78.97. This value exceeds the healthy maximum of 70. It has increased from 75.76 (Mar 23) to 78.97, marking an increase of 3.21.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 79.57. This value exceeds the healthy maximum of 70. It has increased from 76.59 (Mar 23) to 79.57, marking an increase of 2.98.
For Interest Coverage Ratio (X), as of Mar 24, the value is 100.70. This value is within the healthy range. It has decreased from 224.79 (Mar 23) to 100.70, marking a decrease of 124.09.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 84.77. This value is within the healthy range. It has decreased from 197.06 (Mar 23) to 84.77, marking a decrease of 112.29.
For Enterprise Value (Cr.), as of Mar 24, the value is 2,154.92. It has increased from 1,520.56 (Mar 23) to 2,154.92, marking an increase of 634.36.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 13.68. This value exceeds the healthy maximum of 3. It has increased from 11.95 (Mar 23) to 13.68, marking an increase of 1.73.
For EV / EBITDA (X), as of Mar 24, the value is 19.30. This value exceeds the healthy maximum of 15. It has increased from 14.54 (Mar 23) to 19.30, marking an increase of 4.76.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 13.64. This value exceeds the healthy maximum of 3. It has increased from 11.97 (Mar 23) to 13.64, marking an increase of 1.67.
For Retention Ratios (%), as of Mar 24, the value is 78.96. This value exceeds the healthy maximum of 70. It has increased from 75.75 (Mar 23) to 78.96, marking an increase of 3.21.
For Price / BV (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 23) to 0.98, marking an increase of 0.25.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 13.64. This value exceeds the healthy maximum of 3. It has increased from 11.97 (Mar 23) to 13.64, marking an increase of 1.67.
For EarningsYield, as of Mar 24, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Alembic Ltd as of August 9, 2025 is: 90.35

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of August 9, 2025, Alembic Ltd is Overvalued by 15.56% compared to the current share price 107.00

Intrinsic Value of Alembic Ltd as of August 9, 2025 is: 88.59

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of August 9, 2025, Alembic Ltd is Overvalued by 17.21% compared to the current share price 107.00

Last 5 Year EPS CAGR: -1.95%

*Investments are subject to market risks

Strength and Weakness

Unable to fetch valid data for stock valuation.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alembic Ltd:
1. Net Profit Margin: 58.96%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.63% (Industry Average ROCE: 12.14%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 12.29% (Industry Average ROE: 10.41%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 84.77
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.49
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 8.85 (Industry average Stock P/E: 72.59)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Alembic Ltd. is a Public Limited Listed company incorporated on 30/07/1907 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L26100GJ1907PLC000033 and registration number is 000033. Currently Company is involved in the business activities of Real estate activities with own or leased property. Company's Total Operating Revenue is Rs. 214.36 Cr. and Equity Capital is Rs. 51.36 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Realty	Alembic Road, Vadodra Gujarat 390003	alembic.investors@alembic.co.in http://www.alembiclimited.com

Management
Name	Position Held
Mr. Chirayu Amin	Chairman
Mrs. Malika Amin	Managing Director & CEO
Mrs. Rati Desai	Independent Director
Mr. Mayurdhvaj Jadeja	Independent Director
Mr. Sanjeev Shah	Independent Director
Dr. Girish Hirode	Independent Director
Mr. Udit Amin	Director
Mr. Jain Parkash	Director

FAQ

What is the intrinsic value of Alembic Ltd?

Alembic Ltd's intrinsic value (as of 09 August 2025) is ₹90.35 which is 15.56% lower the current market price of 107.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,740 Cr. market cap, FY2025-2026 high/low of 169/85.5, reserves of 2,287 Cr, and liabilities of 2,503 Cr.

What is the Market Cap of Alembic Ltd?

The Market Cap of Alembic Ltd is 2,740 Cr..

What is the current Stock Price of Alembic Ltd as on 09 August 2025?

The current stock price of Alembic Ltd as on 09 August 2025 is 107.

What is the High / Low of Alembic Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Alembic Ltd stocks is 169/85.5.

What is the Stock P/E of Alembic Ltd?

The Stock P/E of Alembic Ltd is 8.85.

What is the Book Value of Alembic Ltd?

The Book Value of Alembic Ltd is 91.1.

What is the Dividend Yield of Alembic Ltd?

The Dividend Yield of Alembic Ltd is 2.25 %.

What is the ROCE of Alembic Ltd?

The ROCE of Alembic Ltd is 6.90 %.

What is the ROE of Alembic Ltd?

The ROE of Alembic Ltd is 13.7 %.

What is the Face Value of Alembic Ltd?

The Face Value of Alembic Ltd is 2.00.